跳至主要内容
临床试验/ACTRN12616000750482
ACTRN12616000750482招募中不适用

In patients with rheumatoid arthritis and inflamed atlantoaxial joint, is intra-articular steroid injection,compared with systemic steroid administration effective and safe?

Diab Fuad Hetta0 个研究点目标入组 60 人开始时间: 2016年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
15 Years 至 70 Years(—)
性别
All

入选标准

  • Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint inflammation and failure of resolution after 2 weeks systemic steroid administration

排除标准

  • Coagulopathy, allergy to contrast material, pregnancy

研究者

发起方
Diab Fuad Hetta

相似试验

进行中(未招募)
1 期
Patients with rheumatoid arthritis and synovitis treated with ultrasound guided intraarticular or intramuscular glucocorticoid injection - A randomised, double-blind, controlled study (Panguian)Treatment of synovitis among rheumatoid arthritis patientsMedDRA version: 21.0Level: PTClassification code 10042868Term: SynovitisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2017-003425-15-DKVidencenter for Reumatologi og Rygsygdomme, Rigshospitalet100
尚未招募
不适用
Mannose-binding lectin (MBL) deficiency is more frequent in rheumatoid arthritis patients with coexistant bronchiectasis than in patients with rheumatoid arthritis alone or bronchiectasis alone.Inflammatory and Immune System - Rheumatoid arthritisRespiratory - Other respiratory disorders / diseasesRheumatoid arthritisBronchiectasis
ACTRN12611000877987Krista Makin150
已完成
不适用
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritis
JPRN-UMIN000016950Osaka Medical College50
招募中
不适用
Rheumatoid Arthritis Patients rePort Onset Reactivatiorheumatoid arthritisarthritis10023213
NL-OMON30946Erasmus MC, Universitair Medisch Centrum Rotterdam150
已完成
不适用
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR StudyRheumatoid Arthritis
JPRN-UMIN000007539niversity of Occupational and Environmental Health, Japan108